99 related articles for article (PubMed ID: 23151473)
1. Virtual screening and QSAR study of some pyrrolidine derivatives as α-mannosidase inhibitors for binding feature analysis.
Moorthy NS; Brás NF; Ramos MJ; Fernandes PA
Bioorg Med Chem; 2012 Dec; 20(24):6945-59. PubMed ID: 23151473
[TBL] [Abstract][Full Text] [Related]
2. Functionalized pyrrolidines inhibit alpha-mannosidase activity and growth of human glioblastoma and melanoma cells.
Fiaux H; Popowycz F; Favre S; Schütz C; Vogel P; Gerber-Lemaire S; Juillerat-Jeanneret L
J Med Chem; 2005 Jun; 48(13):4237-46. PubMed ID: 15974577
[TBL] [Abstract][Full Text] [Related]
3. Using DFT methodology for more reliable predictive models: Design of inhibitors of Golgi α-Mannosidase II.
Bobovská A; Tvaroška I; Kóňa J
J Mol Graph Model; 2016 May; 66():47-57. PubMed ID: 27035259
[TBL] [Abstract][Full Text] [Related]
4. Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site.
Fiaux H; Kuntz DA; Hoffman D; Janzer RC; Gerber-Lemaire S; Rose DR; Juillerat-Jeanneret L
Bioorg Med Chem; 2008 Aug; 16(15):7337-46. PubMed ID: 18599296
[TBL] [Abstract][Full Text] [Related]
5. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
Sun J; Mei H
Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors.
Popowycz F; Gerber-Lemaire S; Demange R; Rodriguez-García E; Asenjo AT; Robina I; Vogel P
Bioorg Med Chem Lett; 2001 Sep; 11(18):2489-93. PubMed ID: 11549453
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.
Shah P; Saquib M; Sharma S; Husain I; Sharma SK; Singh V; Srivastava R; Shaw AK; Siddiqi MI
Bioorg Chem; 2015 Apr; 59():91-6. PubMed ID: 25727263
[TBL] [Abstract][Full Text] [Related]
8. Comparative structural analysis of α-glucosidase inhibitors on difference species: a computational study.
Narayana Moorthy NS; Ramos MJ; Fernandes PA
Arch Pharm (Weinheim); 2012 Apr; 345(4):265-74. PubMed ID: 22006830
[TBL] [Abstract][Full Text] [Related]
9. Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.
Bello C; Cea M; Dal Bello G; Garuti A; Rocco I; Cirmena G; Moran E; Nahimana A; Duchosal MA; Fruscione F; Pronzato P; Grossi F; Patrone F; Ballestrero A; Dupuis M; Sordat B; Nencioni A; Vogel P
Bioorg Med Chem; 2010 May; 18(9):3320-34. PubMed ID: 20346684
[TBL] [Abstract][Full Text] [Related]
10. Conformationally locked thiosugars as potent alpha-mannosidase inhibitors: synthesis, biochemical and docking studies.
Sivapriya K; Hariharaputran S; Suhas VL; Chandra N; Chandrasekaran S
Bioorg Med Chem; 2007 Sep; 15(17):5659-65. PubMed ID: 17574420
[TBL] [Abstract][Full Text] [Related]
11. Discovery of potential new InhA direct inhibitors based on pharmacophore and 3D-QSAR analysis followed by in silico screening.
Lu XY; Chen YD; Jiang YJ; You QD
Eur J Med Chem; 2009 Sep; 44(9):3718-30. PubMed ID: 19428156
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
Zhuo Y; Kong R; Cong XJ; Chen WZ; Wang CX
Eur J Med Chem; 2008 Dec; 43(12):2724-34. PubMed ID: 18538451
[TBL] [Abstract][Full Text] [Related]
13. Dihydroxyacetone phosphate aldolase catalyzed synthesis of structurally diverse polyhydroxylated pyrrolidine derivatives and evaluation of their glycosidase inhibitory properties.
Calveras J; Egido-Gabás M; Gómez L; Casas J; Parella T; Joglar J; Bujons J; Clapés P
Chemistry; 2009 Jul; 15(30):7310-28. PubMed ID: 19579240
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insight into the Binding of Multivalent Pyrrolidines to α-Mannosidases.
Mirabella S; D'Adamio G; Matassini C; Goti A; Delgado S; Gimeno A; Robina I; Moreno-Vargas AJ; Šesták S; Jiménez-Barbero J; Cardona F
Chemistry; 2017 Oct; 23(58):14585-14596. PubMed ID: 28902965
[TBL] [Abstract][Full Text] [Related]
15. Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors.
Zhang J; Pan X; Wang C; Wang F; Li P; Xu W; He L
Chem Biol Drug Des; 2012 Mar; 79(3):353-9. PubMed ID: 22222003
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of anomeric 1,5-anhydrosugars as conformationally locked selective α-mannosidase inhibitors.
Mane RS; Ghosh S; Singh S; Chopade BA; Dhavale DD
Bioorg Med Chem; 2011 Nov; 19(22):6720-5. PubMed ID: 22001328
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
[TBL] [Abstract][Full Text] [Related]
18. Studies of tricyclic piperazine/piperidine furnished molecules as novel integrin αvβ3/αIIbβ3 dual antagonists using 3D-QSAR and molecular docking.
Yan Y; Li Y; Zhang S; Ai C
J Mol Graph Model; 2011 Feb; 29(5):747-62. PubMed ID: 21273104
[TBL] [Abstract][Full Text] [Related]
19. α-D-mannose derivatives as models designed for selective inhibition of Golgi α-mannosidase II.
Poláková M; Šesták S; Lattová E; Petruš L; Mucha J; Tvaroška I; Kóňa J
Eur J Med Chem; 2011 Mar; 46(3):944-52. PubMed ID: 21295890
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a 2-aryl polyhydroxylated pyrrolidine alkaloid-based library.
Tsou EL; Chen SY; Yang MH; Wang SC; Cheng TR; Cheng WC
Bioorg Med Chem; 2008 Dec; 16(24):10198-204. PubMed ID: 19008111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
